NCT06846229

Brief Summary

The study builds and applies an AI model to help doctors predict patient diagnoses and outcomes, such as survival or hospital stay. Real-time, multimodal data (labs, vital signs, history, imaging) from hospital records will be used. Patients will be tracked to compare the AI's performance with standard care. The goal is to improve diagnosis and treatment accuracy in a real-world, prospective study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50,000,000

participants targeted

Target at P75+ for all trials

Timeline
0mo left

Started Feb 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Feb 2025Jun 2026

First Submitted

Initial submission to the registry

February 24, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

February 24, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 26, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 3, 2025

Status Verified

February 1, 2025

Enrollment Period

1.3 years

First QC Date

February 24, 2025

Last Update Submit

February 27, 2025

Conditions

Keywords

diagnosispredictionAIoutcome

Outcome Measures

Primary Outcomes (4)

  • Area Under the Curve (AUC)

    AUC of the ROC curve, used to quantify diagnostic accuracy. No unit (a ratio or percentage, typically expressed as a number between 0 and 1).

    1 year

  • Overall Hospital Resource Utilization Improvement

    The percentage reduction in overall hospital resource use (e.g., bed days, ICU admissions, diagnostic tests) attributed to AI-assisted decision-making, expressed as a percentage.

    1 year

  • Population-Level Diagnostic Accuracy Enhancement

    The overall improvement in diagnostic accuracy across all hospital patients (e.g., percentage of correct diagnoses or reduction in misdiagnoses) facilitated by the AI model, expressed as a percentage or ratio.

    1 year

  • System-Wide Reduction in Adverse Event Rates

    The percentage reduction in major adverse events (e.g., mortality, severe complications, or prolonged stays) across all hospital patients due to AI-assisted decision-making, expressed as a percentage.

    1 year

Secondary Outcomes (4)

  • Overall Improvement in Hospital Patient Outcomes

    1 year

  • Enhancement of Healthcare System Efficiency

    1 year

  • Population Health Impact Score

    1 year

  • Long-Term Public Health Benefit Index

    1 year

Study Arms (1)

Hospital-Wide Patient Cohort

Other: AI-associated strategy

Interventions

The intervention in this study involves an AI system that leverages multimodal data fusion to support the clinical decision-making and evaluation of diseases. Patients in this cohort will undergo standard examinations, with clinical decisions guided by the recommendations generated by the AI system.

Hospital-Wide Patient Cohort

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study includes all patients admitted to any hospital department, with real-time electronic health record data (e.g., labs, vital signs, history, imaging). Participants must consent to data collection.

You may qualify if:

  • Patients admitted to any department of the hospital (e.g., ICU, general wards, emergency, outpatient services) during the study period.
  • Patients with available real-time electronic health record (EHR) data, including at least two of the following: laboratory results, vital signs, medical history, and imaging data.

You may not qualify if:

  • Patients currently enrolled in another clinical trial that could interfere with data collection or outcomes of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

RECRUITING

Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

RECRUITING

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Scientist

Study Record Dates

First Submitted

February 24, 2025

First Posted

February 26, 2025

Study Start

February 24, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 3, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations